Life science company Acucort has been granted trademark protection for Zeqmelit in Ukraine, according to a press release. The protection is part of the pharmaceutical company’s ongoing commercialization phase.Glenmark Pharmaceuticals, with which Acucort signed a commercial partnership agreement in January 2026, will be responsible for distribution, marketing and sales in Ukraine. The trademark protection will be renewed in connection with the international registration on 9 January 2033.